Challenbio
Latest round
- Series B
Last raised
- Jul 2026
Total raised
- $14M
Investors
- 4
About Challenbio
, trading under the name Challenbio, provides flow cytometry detection solutions for the biopharmaceutical and clinical diagnostic sectors. The founder of the company is Tiefu Liu who graduated from the College of Mechanical Engineering, Tsinghua University, and has participated in the R&D of clinical flow cytometer equipment at Mindray Beijing Research Institute in 2007. The company has R&D offices in Daxing and Changping and a wholly-owned subsidiary in Hunan. Its products have acquired CE certification. The company works with research institutions, hospitals, and biopharmaceutical enterprises to provide comprehensive flow cytometry systems. The hardware portfolio includes clinical devices such as the MateCyte, LongCyte, and ClinStellar spectrum systems, alongside scientific equipment like the FongCyte, ElaraCyte, and CytoStellar series. The firm also provides clinical immune assessment reagents integrated with volumetric absolute counting technology for automated clinical screening. The company generates revenue from B2B contracts for the commercial sale of flow cytometers and diagnostic reagent consumables to scientific research institutions and medical diagnostic centers.
Who invested in Challenbio
4 investors across 3 rounds
See all investors in Challenbio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Challenbio
Who invested in Challenbio?
Challenbio has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Challenbio raised?
Challenbio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Challenbio last raise money?
Challenbio's most recent round on record is a Series B, in Jul 2026.
What does Challenbio do?
, trading under the name Challenbio, provides flow cytometry detection solutions for the biopharmaceutical and clinical diagnostic sectors.
Where is Challenbio headquartered?
Challenbio is headquartered in Beijing, China.
Which VCs invest in companies like Challenbio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Challenbio's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Challenbio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.